Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Samira Farhadi
Observed name:
Samira A. Farhadi
Institution:
University of Nizwa
Observed institutions:
University of Nizwa,
University of Guilan
ORCID:
0009-0007-6440-1523
Observed ORCID:
0009-0007-6440-1523
OpenAlex ID:
A5116547178
Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reduction
2025
·
Samira Farhadi
, Saeed Mohammadi
, et al.
·
World Journal of Biological Chemistry
·
5
Welfare aspects of dromedary camels (Camelus dromedarius) and their impact on meat quality: Review
2026
·
Isam T. Kadim
, Issa S. Al-Amri
, et al.
·
Veterinary and Animal Science
PDF
Ursolic Acid in Cancer Therapy: Mechanistic Insights into Apoptosis, Angiogenesis, Cell Cycle Arrest, and Metastasis
2026
·
Issa S. Al-Amri
, Samira Farhadi
, et al.
·
Current Molecular Medicine
Synergistic induction of apoptosis and metabolic reprogramming by ursolic acid and acetyl-11-keto-β-boswellic acid in chemoresistant ovarian cancer cell lines
2026
·
Issa S. Al-Amri
, Samira Farhadi
, et al.
·
Scientific Reports
PDF
Perspective Chapter: Molecular Determinants of Therapeutic Response in Preclinical Animal Models – From Mechanistic Insights to Translational Precision Medicine
2026
·
Issa S. Al-Amri
, Samira Farhadi
, et al.
·
IntechOpen eBooks
PDF
Single-Cell and Computational Epigenomics in HGSOC: A Roadmap to Overcoming Chemoresistance
2026
·
Samira A. Farhadi
, Issa S. Al-Amri
·
Current Cancer Drug Targets
Design and synthesis of novel triazole-metronidazole boswellic acid hybrids for ovarian cancer targeting
2026
·
Sadiq Noor Khan
, Samira Farhadi
, et al.
·
European Journal of Medicinal Chemistry
Show more works
View as search
Works count:
7
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type